Get the Stockscreener App
0.5899
1.63%
-0.0098
After Hours:
.59
0.000100
+0.02%
Reviva Pharmaceuticals Holdings Inc stock is traded at $0.5899, with a volume of 6.34M.
It is down -1.63% in the last 24 hours and up +8.24% over the past month.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
See More
Previous Close:
$0.5997
Open:
$0.62
24h Volume:
6.34M
Relative Volume:
0.72
Market Cap:
$40.90M
Revenue:
-
Net Income/Loss:
$-27.11M
P/E Ratio:
-0.9075
EPS:
-0.65
Net Cash Flow:
$-26.55M
1W Performance:
-0.29%
1M Performance:
+8.24%
6M Performance:
-31.95%
1Y Performance:
-39.65%
1-Day Range:
$0.57
$0.6499
1-Week Range:
$0.55
$0.6499
52-Week Range:
$0.2522
$4.28
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Name
Reviva Pharmaceuticals Holdings Inc
Sector
Industry
Phone
(408) 501-8881
Address
10080 N WOLFE ROAD, CUPERTINO
Compare RVPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.5899 | 57.77M | 0 | -27.11M | -26.55M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-29-25 | Initiated | Chardan Capital Markets | Buy |
| Sep-20-23 | Initiated | ROTH MKM | Buy |
| Jun-08-23 | Initiated | The Benchmark Company | Speculative Buy |
| Jan-24-22 | Initiated | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Latest News
Price action breakdown for Reviva Pharmaceuticals Holdings Inc. Equity WarrantQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Is Reviva Pharmaceuticals Holdings Inc. forming a bottoming basePortfolio Risk Summary & Fast Gaining Stock Strategy Reports - newser.com
Visual trend scoring systems applied to Reviva Pharmaceuticals Holdings Inc. Equity WarrantJuly 2025 Trends & Precise Swing Trade Entry Alerts - newser.com
What indicators show strength in Reviva Pharmaceuticals Holdings Inc. Equity WarrantJuly 2025 Trends & High Conviction Trade Alerts - newser.com
Has Reviva Pharmaceuticals Holdings Inc. found a price floorJuly 2025 EndofMonth & Low Drawdown Momentum Ideas - newser.com
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock trades before earningsMarket Growth Review & High Conviction Investment Ideas - newser.com
Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock affected by interest rate hikes2025 Sector Review & Safe Capital Preservation Plans - newser.com
What recovery options are there for Reviva Pharmaceuticals Holdings Inc.July 2025 Short Interest & Safe Capital Growth Trade Ideas - newser.com
Applying Elliott Wave Theory to Reviva Pharmaceuticals Holdings Inc. Equity WarrantTrade Exit Report & Technical Entry and Exit Alerts - newser.com
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock performs after earningsQuarterly Earnings Report & Long-Term Capital Growth Strategies - newser.com
Risk adjusted return profile for Reviva Pharmaceuticals Holdings Inc. Equity Warrant analyzedBuy Signal & Accurate Entry and Exit Point Alerts - newser.com
Published on: 2025-11-03 02:11:00 - newser.com
Published on: 2025-11-03 02:08:28 - newser.com
Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock dividend yield sustainableEarnings Miss & High Conviction Investment Ideas - newser.com
Statistical indicators supporting Reviva Pharmaceuticals Holdings Inc.’s strengthTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Long term hold vs stop loss in Reviva Pharmaceuticals Holdings Inc.July 2025 Opening Moves & Community Driven Trade Alerts - newser.com
Order flow analysis tools used on Reviva Pharmaceuticals Holdings Inc. Equity WarrantJuly 2025 Volume & Consistent Profit Trading Strategies - newser.com
Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock reach all time highs in 2025Quarterly Earnings Summary & Real-Time Volume Analysis - newser.com
Why Reviva Pharmaceuticals Holdings Inc. stock is popular among millennialsMarket Trend Report & Community Verified Watchlist Alerts - newser.com
Key resistance and support levels for Reviva Pharmaceuticals Holdings Inc.July 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com
What drives Namura Shipbuilding Co Ltd 8AF stock priceMarket Timing Techniques & Learn What Analysts Rate “Strong Buy” - earlytimes.in
Forecasting Reviva Pharmaceuticals Holdings Inc. Equity Warrant price range with options dataWeekly Investment Recap & Fast Moving Market Watchlists - newser.com
Price momentum metrics for Reviva Pharmaceuticals Holdings Inc. Equity Warrant explained2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Is it time to cut losses on Reviva Pharmaceuticals Holdings Inc.Quarterly Performance Summary & Technical Pattern Based Signals - newser.com
Intraday pattern recognizer results for Reviva Pharmaceuticals Holdings Inc. Equity WarrantTrade Signal Summary & Expert Approved Momentum Trade Ideas - newser.com
Published on: 2025-11-02 12:27:45 - newser.com
Is Reviva Pharmaceuticals Holdings Inc. stock positioned for digital transformationTrade Entry Summary & Weekly Breakout Stock Alerts - newser.com
Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock chart pattern explainedPortfolio Value Summary & AI Optimized Trading Strategy Guides - newser.com
Historical volatility pattern of Reviva Pharmaceuticals Holdings Inc. visualizedPrice Action & AI Driven Stock Movement Reports - newser.com
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):